Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
04/11/20 je Re: COVID-19 PowerPlan Update
April 13, 2020
From: "Jonathan Edwards" <jonathan.edwards@hhsys.org>
Sent: Saturday, April 11, 2020 12:08:56 PM
Subject: Re: COVID-19 PowerPlan Update
Pharmacists,
I wanted to give everyone an update on the currently available PowerPlans for our COVID-19 patients.
- Hydroxychloroquine - **Active Now**
- All orders for COVID-19 (+) patients will need to be entered using the "ID COVID-19 Hydroxychloroquine (PLAQUENIL) Adult Orders" PowerPlan
- This will allow for the correct dose and duration of therapy to be ordered for this patient population
- Hydroxychloroquine 400 mg PO q 12 hours x 2 doses then 200 mg PO q 12 hours x 8 doses
- IL-6 Medications - **Active Now**
- The use of IL-6 medications is currently restricted to ID physicians and must comply with a use criteria
- All orders for COVID-19 (+) patients will need to be entered using the "ID COVID-19 Sarilumab/Siltuximab/Tocilizumab Consult to Pharmacy" PowerPlan
- When a physician orders one of these medications, it will generate a consult to pharmacy
- If you receive this consult, please notify AMT (5-0286) or the Hotline after-hours (256-469-8560)
- AMT will work with the prescribing physician to determine if the patient meets criteria to receive this medication as well as agree upon a dose based on our current medication availability
- Azithromycin - **Coming Soon**
- Use of azithromycin in COVID-19 patients is controversial
- We are developing a community acquired pneumonia (CAP) PowerPlan (ID Intravenous Azithromycin for Community-Acquired Pneumonia) to help facilitate the current recommended dosing with appropriate duration of therapy for both CAP and COVID-19
- Azithromycin 500 mg IV x 1 dose then 250 mg IV q 24 hours x 4 doses
Thank you so much for all you are doing! Please let AMT know if you have any questions.